Adverse effects of sodium-glucose cotransporter-2 inhibitors in patients with heart failure: a systematic review and meta-analysis
Andrea Pozzi(Ospedale Valduce), Giacomo Corrado(Agostino Gemelli University Polyclinic), Søren Lund Kristensen(Novo Nordisk (Denmark)), Alfonso Iorio(Impact), Federico Rea(University of Milano-Bicocca), E. Tavano(Ospedale di Circolo di Busto Arsizio), Carlo Cirelli(Ospedale Papa Giovanni XXIII), Anna Merlo(Ospedale Papa Giovanni XXIII), C. Scangiuzzi(Ospedale Papa Giovanni XXIII), Chi Kin Wong(Lunenfeld-Tanenbaum Research Institute), Attilio Iacovoni(Ospedale Papa Giovanni XXIII)
Cited by 8
Related Papers
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
|The Lancet Diabetes & Endocrinology|2019|1.6k
Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis
|BMJ|2011|274
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
|Endocrine Reviews|2020|268